End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.35 CNY | +0.68% | +4.62% | -13.59% |
Apr. 10 | Chongqing Pharscin Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2023 | CI |
Apr. 03 | Pharscin Pharma Gets License to Produce Olmesartan Medoxomil Amlodipine Tablets | MT |
Sales 2021 | 846M 117M | Sales 2022 | 785M 108M | Capitalization | 8.5B 1.17B |
---|---|---|---|---|---|
Net income 2021 | 91M 12.56M | Net income 2022 | 98M 13.53M | EV / Sales 2021 | 8.26 x |
Net cash position 2021 | 259M 35.81M | Net cash position 2022 | 503M 69.47M | EV / Sales 2022 | 10.2 x |
P/E ratio 2021 |
78.9
x | P/E ratio 2022 |
83.4
x | Employees | 1,416 |
Yield 2021 |
0.28% | Yield 2022 |
0.34% | Free-Float | 9.66% |
1 day | +0.68% | ||
1 week | +4.62% | ||
Current month | -4.78% | ||
1 month | -6.90% | ||
3 months | -10.64% | ||
6 months | -18.84% | ||
Current year | -13.59% |
Managers | Title | Age | Since |
---|---|---|---|
Xiao Ying Liu
CEO | Chief Executive Officer | 61 | 15-08-18 |
Kai Yu Xu
CHM | Chairman | 58 | 00-09-30 |
Xiao Yan Peng
DFI | Director of Finance/CFO | 50 | 02-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jia Ming Li
BRD | Director/Board Member | 58 | 22-05-17 |
Hong Tao You
CHM | Chairman | 61 | 15-08-18 |
Xiao Ying Liu
CEO | Chief Executive Officer | 61 | 15-08-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 13.35 | +0.68% | 3,522,891 |
24-04-24 | 13.26 | +1.14% | 1,578,711 |
24-04-23 | 13.11 | +2.10% | 2,247,120 |
24-04-22 | 12.84 | +0.31% | 1,651,301 |
24-04-19 | 12.8 | +0.31% | 1,252,201 |
End-of-day quote Shenzhen S.E., April 24, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-13.59% | 770M | |
+20.44% | 21.89B | |
+13.49% | 14.45B | |
+13.01% | 13.63B | |
+37.26% | 11.49B | |
-8.59% | 6.85B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+6.35% | 5.06B | |
-5.36% | 4.66B |
- Stock Market
- Equities
- 002907 Stock